2024
2023 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for the Management of Headache.
Sico J, Antonovich N, Ballard-Hernandez J, Buelt A, Grinberg A, Macedo F, Pace I, Reston J, Sall J, Sandbrink F, Skop K, Stark T, Vogsland R, Wayman L, Ford A. 2023 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for the Management of Headache. Annals Of Internal Medicine 2024 PMID: 39467289, DOI: 10.7326/annals-24-00551.Peer-Reviewed Original ResearchClinical practice guidelinesU.S. Department of Veterans AffairsTension-type headacheDepartment of Veterans AffairsVeterans AffairsManagement of headacheCalcitonin gene-related peptidePractice guidelinesEpisodic migraineDefense Clinical Practice GuidelinesPrimary care cliniciansManagement of tension-type headacheRevised CPGTreatment of tension-type headacheDepartment of Defense Clinical Practice GuidelinesChronic tension-type headacheCalcitonin gene-related peptide monoclonal antibodiesTreatment of acute migrainePrevention of chronic migraineAerobic exerciseCare cliniciansPreventing episodic migrainePhysical therapyNonpharmacological interventionsSecondary headache disorders
2023
Calcitonin Gene–Related Peptide Monoclonal Antibodies and Risk of SARS-CoV-2 Infection and Severe COVID-19 Outcomes Among Veterans With Migraine Disorder
Wang K, Fenton B, Deng Y, Anthony S, Dao V, Schindler E, Lipton R, Guirguis A, Skanderson M, Seng E, Sico J. Calcitonin Gene–Related Peptide Monoclonal Antibodies and Risk of SARS-CoV-2 Infection and Severe COVID-19 Outcomes Among Veterans With Migraine Disorder. JAMA Network Open 2023, 6: e2326371. PMID: 37523183, PMCID: PMC10391301, DOI: 10.1001/jamanetworkopen.2023.26371.Peer-Reviewed Original ResearchConceptsCalcitonin gene-related peptideSARS-CoV-2 infectionSevere COVID-19 outcomesCGRP mAbsMechanical ventilationSupplemental oxygenCOVID-19 outcomesSARS-CoV-2Cohort studyCGRP antagonistMAIN OUTCOMEMigraine disordersPositive SARS-CoV-2 test resultSARS-CoV-2 test resultsCOVID-19Protocol hazard ratiosRetrospective cohort studyMonoclonal antibody treatmentGene-related peptideLikelihood of hospitalizationCourse of diseasePeptide monoclonal antibodyElectronic health recordsNeuroimmune modulatorCumulative incidence